Literature DB >> 3147526

Antibiotic resistance in Neisseria gonorrhoeae: genetics and mechanisms of resistance.

S R Johnson1, S A Morse.   

Abstract

In recent years the emergence and spread of antibiotic resistance in Neisseria gonorrhoeae has increased markedly. Chromosomal resistance to penicillin and tetracycline is due to the effects of one or more mutations and is generally low-level. However, the effects of these mutations are additive. Thus, the level of resistance in strains with several mutations is often high enough to yield significant rates of treatment failure. Resistance to aminoglycosides (e.g., streptomycin and kanamycin) and spectinomycin, an aminocyclitol antibiotic is not due to the inactivation of the antibiotic but to an alteration in the sensitivity of the 30S ribosomal subunit to the drug. At least five beta-lactamase plasmids of N. gonorrhoeae have been described. Some of these plasmids can be mobilized by the 24.5-MDa gonococcal conjugative plasmid and transferred to other gonococcal strains. Gonococci have recently acquired high-level resistance to tetracycline due to the streptococcal tetM determinant. This determinant is located on a 25.2-MDa plasmid that possesses a considerable degree of homology with the 24.5-MDa conjugative plasmid. The 25.2-MDa plasmid has retained the ability to transfer beta-lactamase plasmids as well as to mobilize and transfer itself to suitable recipient strains.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3147526     DOI: 10.1097/00007435-198810000-00008

Source DB:  PubMed          Journal:  Sex Transm Dis        ISSN: 0148-5717            Impact factor:   2.830


  15 in total

1.  marA, a regulated locus which controls expression of chromosomal multiple antibiotic resistance in Escherichia coli.

Authors:  H Hächler; S P Cohen; S B Levy
Journal:  J Bacteriol       Date:  1991-09       Impact factor: 3.490

Review 2.  Antimicrobial resistance in Neisseria gonorrhoeae in the 21st century: past, evolution, and future.

Authors:  Magnus Unemo; William M Shafer
Journal:  Clin Microbiol Rev       Date:  2014-07       Impact factor: 26.132

3.  Comparative assessment of Etest for testing susceptibilities of Neisseria gonorrhoeae to penicillin, tetracycline, ceftriaxone, cefotaxime, and ciprofloxacin: investigation using 510(k) review criteria, recommended by the Food and Drug Administration.

Authors:  D J Biedenbach; R N Jones
Journal:  J Clin Microbiol       Date:  1996-12       Impact factor: 5.948

4.  Ciprofloxacin-induced, low-level resistance to structurally unrelated antibiotics in Pseudomonas aeruginosa and methicillin-resistant Staphylococcus aureus.

Authors:  J Fung-Tomc; B Kolek; D P Bonner
Journal:  Antimicrob Agents Chemother       Date:  1993-06       Impact factor: 5.191

Review 5.  Antimicrobial susceptibility testing of Neisseria gonorrhoeae and implications for epidemiology and therapy.

Authors:  T Fekete
Journal:  Clin Microbiol Rev       Date:  1993-01       Impact factor: 26.132

Review 6.  Bacterial resistance to tetracycline: mechanisms, transfer, and clinical significance.

Authors:  B S Speer; N B Shoemaker; A A Salyers
Journal:  Clin Microbiol Rev       Date:  1992-10       Impact factor: 26.132

7.  Genetic and functional analysis of the multiple antibiotic resistance (mar) locus in Escherichia coli.

Authors:  S P Cohen; H Hächler; S B Levy
Journal:  J Bacteriol       Date:  1993-03       Impact factor: 3.490

Review 8.  Antimicrobial Resistance Expressed by Neisseria gonorrhoeae: A Major Global Public Health Problem in the 21st Century.

Authors:  Magnus Unemo; Carlos Del Rio; William M Shafer
Journal:  Microbiol Spectr       Date:  2016-06

9.  Comparison of E test with agar dilution for antimicrobial susceptibility testing of Neisseria gonorrhoeae.

Authors:  E Van Dyck; H Smet; P Piot
Journal:  J Clin Microbiol       Date:  1994-06       Impact factor: 5.948

Review 10.  An insight into the drug resistance profile & mechanism of drug resistance in Neisseria gonorrhoeae.

Authors:  Achchhe Lal Patel; Uma Chaudhry; Divya Sachdev; Poonam Nagpal Sachdeva; Manju Bala; Daman Saluja
Journal:  Indian J Med Res       Date:  2011-10       Impact factor: 2.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.